First Health Pharmaceuticals will participate in the workshop organized by Oncode Institute dedicated to glioblastoma. The workshop will be held on October 16th 2019, in Rotterdam, in the Erasmus Medical Center (EMC).
Besides presenting current trends on the disease, the Oncode Institute‘s workshop aims at addressing the unmet needs on glioblastoma treatment research by bringing together research and clinical institutes. Keynote speakers from important Dutch research and clinical institutes and will highlight current trends on glioblastoma and stress the importance of collaboration between translational and clinical approaches to enhance treatment research.
First Health Pharmaceuticals has been developing important research projects dedicated to glioblastoma based on its strong belief that collaboration between research and clinical institutes is key to treatment research.
